In the rapidly advancing field of gene therapy, adeno-associated viruses (AAV)stand out as powerful tools with immense potential. These vectors offer a precise means of delivering genetic material. However, ensuring their effectiveness and safety requires careful consideration of immunogenicity. To ... Read more
In the dynamic field of gene therapy, understanding the complexities of Adeno-Associated virus (AAV) immunogenicity is crucial for achieving success. Managing pre-existing neutralizing antibodies (NAbs) and Total Antibodies (TAbs) toward AAV capsids poses a significant challenge, potentially ... Read more
